Home
The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.
First participant enrolled in Gritstone second generation COVID-19 vaccine study
This early phase clinical trial is being conducted through the NIAID-supported IDCRC to assess the safety and tolerability of different doses of two-part investigational COVID-19 vaccine regimens that include bits of other SARS-CoV-2 proteins in addition to the spike.
IDCRC News
COVID-19 Prevention Network
The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.
More about the CoVPN
IDCRC Sites Across the Nation
VTEU COVID-19 Trials
About
The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.

IDCRC Leadership Group










IDCRC Concept Quick Stats
ICP Status
- Approved: 20
- Administratively Not Supported: 16
- Revise & Resubmit: 7
- Withdrawn: 6
- EWG Liaisons: 1
- EWGs: 4
- Not Approved: 23
- EMT: 0
- Other: 2
EWG Assignment
- COVID: 62
- Respiratory: 9
- STI: 2
- Malaria/Topical Diseases: 3
- Enteric Infections: 0
- Emerging Infections: 3
ECP
- Protocol Development: 7
- Submitted to ACTIVE Mab Program per DMID: 1
- Transitioned to CoVPN Trial: 1
- Transitioned to ACTT 2: 1
- Funded by NIAID via Other Mechanism: 1
- Pending: 5
- In Process: 3
- Not Approved: 0
- On Hold: 2
- Note: Protocols Transitioned to IDCRC for Protocol Implementation: 5